INNOVATE (NYSE:VATE – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.18) by $2.89, FiscalAI reports. The company had revenue of $421.60 million during the quarter, compared to analysts’ expectations of $251.70 million.
Here are the key takeaways from INNOVATE’s conference call:
- Q2 results improved substantially: Revenue rose 74.2% year over year to $421.6 million, Adjusted EBITDA increased to $46.3 million from $15.7 million, and net income attributable to stockholders reached $10.4 million versus a $22 million loss a year ago.
- Infrastructure delivered a record quarter, with DBMG revenue up 77.6% to $414 million and Adjusted EBITDA reaching $48.7 million. Adjusted backlog expanded to $2.7 billion, supported by demand from data centers, technology, healthcare, semiconductors, energy systems, and digital connectivity.
- INNOVATE refinanced Broadcasting with $105 million of financing and agreed to sell CONX a controlling 75% interest, while retaining 25% and an option to increase its stake to 40%. CONX also committed up to $75 million of post-closing equity capital, although closing remains subject to FCC and other regulatory approvals.
- MediBeacon reported continued progress in commercial placements and is engaging with more than 100 healthcare institutions, while pursuing reimbursement and regulatory initiatives. Its Lumitrace marketing authorization application in Europe is targeted for filing in 2027, indicating meaningful commercialization opportunities remain longer term.
- Liquidity and financing remain constraints in parts of the portfolio: consolidated cash declined to $87.8 million from $108.2 million at year-end, total debt rose to $626.4 million, and R2’s revenue fell 31.3% due partly to liquidity-related reductions in unit sales. R2 is seeking additional capital to fund inventory, manufacturing, and commercial expansion.
INNOVATE Stock Up 65.6%
Shares of VATE stock opened at $12.27 on Friday. The firm has a market cap of $167.42 million, a price-to-earnings ratio of -6.56 and a beta of 2.35. INNOVATE has a 52-week low of $3.75 and a 52-week high of $21.30. The company’s 50 day moving average is $13.45 and its 200 day moving average is $9.79.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on VATE
Institutional Trading of INNOVATE
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC bought a new position in shares of INNOVATE in the 4th quarter worth $51,000. Squarepoint Ops LLC purchased a new position in INNOVATE in the third quarter valued at about $58,000. Bank of America Corp DE grew its stake in INNOVATE by 13.4% in the third quarter. Bank of America Corp DE now owns 18,962 shares of the company’s stock valued at $93,000 after purchasing an additional 2,236 shares during the last quarter. Finally, Citadel Advisors LLC grew its stake in INNOVATE by 60.2% in the third quarter. Citadel Advisors LLC now owns 37,694 shares of the company’s stock valued at $184,000 after purchasing an additional 14,163 shares during the last quarter. Institutional investors own 34.28% of the company’s stock.
INNOVATE Company Profile
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.
See Also
- Five stocks we like better than INNOVATE
- Why These 3 Equal Weight ETFs Have Outperformed the S&P This Year
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
Receive News & Ratings for INNOVATE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INNOVATE and related companies with MarketBeat.com's FREE daily email newsletter.
